Real-time SEC alerts Start Free →
Profitelligence
Becton, Dickinson and Company
BDX MEDIUM Impact

Becton, Dickinson and Company

Becton, Dickinson and Company Announces New Debt Issuance

| 8-K |Healthcare

Summary

On May 11, 2026, Becton, Dickinson and Company, through its subsidiary Becton Dickinson Euro Finance S.à r.l., entered into an underwriting agreement for the issuance of €600,000,000 aggregate principal amount of 3.855% Euro Notes due 2033. The notes are fully and unconditionally guaranteed by BD. The net proceeds, together with cash on hand, will be used to repay €1.208% Euro Notes due June 4, 2026, and to pay related fees and expenses. The offering is expected to be completed on or about May 20, 2026, subject to customary closing conditions.

Profitelligence Profitelligence Alerts

Get alerts for BDX

Be first to know when Becton, Dickinson and Company files with the SEC.

Set Up Alerts →

Filing Categories

New Debt Issued

Advertisement

About Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is a prominent American multinational corporation engaged in the development and manufacture of a diverse range of medical devices, instrument systems, and reagents. A key player in the healthcare industry, BD focuses on improving medical discovery, diagnostics, and the delivery of care. BD's products are instrumental in supporting healthcare professionals worldwide in enhancing patient safety and reducing the risks associated with healthcare workers. The company operates across three main segments: BD Medical, BD Life Sciences, and BD Interventional, impacting various sectors such as pharmaceuticals, hospital healthcare systems, and clinical laboratories. With a strong commitment to innovation and quality, Becton, Dickinson and Company contributes significantly to advancements in patient care, operating efficiency in medical settings, and is noted for its commitment to addressing healthcare challenges on a global scale. Headquartered in Franklin Lakes, New Jersey, BD maintains a robust presence across numerous countries, underpinning its influential role in the evolution and improvement of global healthcare infrastructure.

Exchange: NYSE Industry: Medical Instruments & Supplies Company Website →

Official SEC Documents

BDX
BDX Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement